ES2109682T3 - Derivados antipsicoticos de imidazoles. - Google Patents

Derivados antipsicoticos de imidazoles.

Info

Publication number
ES2109682T3
ES2109682T3 ES94910462T ES94910462T ES2109682T3 ES 2109682 T3 ES2109682 T3 ES 2109682T3 ES 94910462 T ES94910462 T ES 94910462T ES 94910462 T ES94910462 T ES 94910462T ES 2109682 T3 ES2109682 T3 ES 2109682T3
Authority
ES
Spain
Prior art keywords
imidazoles
derivatives
substituted
dopamine
antipsychotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94910462T
Other languages
English (en)
Spanish (es)
Inventor
Janusz Jozef Kulagowski
Paul David Leeson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Application granted granted Critical
Publication of ES2109682T3 publication Critical patent/ES2109682T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES94910462T 1993-03-30 1994-03-23 Derivados antipsicoticos de imidazoles. Expired - Lifetime ES2109682T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939306578A GB9306578D0 (en) 1993-03-30 1993-03-30 Therapeutic agents

Publications (1)

Publication Number Publication Date
ES2109682T3 true ES2109682T3 (es) 1998-01-16

Family

ID=10732977

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94910462T Expired - Lifetime ES2109682T3 (es) 1993-03-30 1994-03-23 Derivados antipsicoticos de imidazoles.

Country Status (10)

Country Link
US (1) US5792768A (de)
EP (1) EP0691960B1 (de)
JP (1) JPH08508289A (de)
AT (1) ATE160774T1 (de)
AU (1) AU679049B2 (de)
CA (1) CA2159220A1 (de)
DE (1) DE69407176T2 (de)
ES (1) ES2109682T3 (de)
GB (1) GB9306578D0 (de)
WO (1) WO1994022839A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633377A (en) * 1990-12-28 1997-05-27 Neurogen Corporation 4-piperidino- and piperazinomethyl-2-cyclohexyl imidazole derivatives; dopamine receptor subtype specific ligands
GB9305644D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
EP0793653A1 (de) * 1994-11-23 1997-09-10 Neurogen Corporation Einige 4-aminomethyl-2-substituierte imidazolderivate und 2-aminomethyl - 4 - substituierte imidazolderivate; neue klassen von spezifischen liganden des dopaminrezeptorsubtyps
US5773616A (en) * 1995-02-15 1998-06-30 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
WO1996025411A1 (en) * 1995-02-15 1996-08-22 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
US5912246A (en) * 1995-02-15 1999-06-15 Pharmacia & Upjohn Company Imidazo 1,2-a!pyridines for the treatment of CNS and cardiac diseases
US5948912A (en) * 1995-02-15 1999-09-07 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
US6187774B1 (en) * 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
DE19637237A1 (de) 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate
HUP0000189A3 (en) 1996-11-15 2002-01-28 Darwin Discovery Ltd Milton Ro Bicyclic aryl carboxamides pharmaceutical compositions containing them and their therapeutic use
US6359882B1 (en) 1997-04-01 2002-03-19 Yipes Communications, Inc. Method and apparatus for transmitting data
US6013654A (en) * 1997-08-14 2000-01-11 Pharmacia & Upjohn Company Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases
US6166205A (en) * 1998-09-02 2000-12-26 Neurogen Corporation 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
CN1325397A (zh) * 1998-09-30 2001-12-05 纽罗根公司 2-哌嗪烷基氨基苯并吡咯衍生物∶多巴胺受体亚型特异配体
US6284759B1 (en) 1998-09-30 2001-09-04 Neurogen Corporation 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
DE60009154D1 (de) * 1999-12-30 2004-04-22 Lundbeck & Co As H Phenylpiperazinyl-derivate
IL153884A0 (en) * 2000-07-20 2003-07-31 Neurogen Corp Capsaicin receptor ligands
CZ2003952A3 (cs) * 2000-10-31 2003-11-12 Basf Drucksysteme Gmbh Použití hyperrozvětvených polyurethanů
US7022728B2 (en) * 2001-03-09 2006-04-04 Abbott Laboratories Benzimidazoles that are useful in treating male sexual dysfunction
US20020169166A1 (en) * 2001-03-09 2002-11-14 Cowart Marlon D. Benzimidazoles that are useful in treating sexual dysfunction
KR100863147B1 (ko) * 2001-03-09 2008-10-13 아보트 러보러터리즈 벤즈이미다졸 및 이를 포함하는 성 기능장애 치료용 약제학적 조성물
US6960589B2 (en) * 2001-03-09 2005-11-01 Abbott Laboratories Benzimidazoles that are useful in treating sexual dysfunction
WO2003060475A2 (en) * 2002-01-10 2003-07-24 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
AU2003212882A1 (en) 2002-02-01 2003-09-02 Euro-Celtique S.A. 2 - piperazine - pyridines useful for treating pain
US7057042B2 (en) 2002-05-29 2006-06-06 Abbott Laboratories Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
WO2003101994A1 (en) * 2002-05-29 2003-12-11 Abbott Laboratories Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
DE60318875T2 (de) * 2002-06-28 2009-01-15 Euro-Celtique S.A. Therapeutische piperazin-derivate für die behandlung von schmerzen
US7262194B2 (en) * 2002-07-26 2007-08-28 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US20040127504A1 (en) * 2002-09-06 2004-07-01 Cowart Marlon D. Benzimidazoles that are useful in treating sexual dysfunction
US7157462B2 (en) 2002-09-24 2007-01-02 Euro-Celtique S.A. Therapeutic agents useful for treating pain
NZ555491A (en) * 2005-01-03 2010-01-29 Univ Siena Aryl piperazine derivatives for the treatment of neuropsychiatric disorders
US7544685B2 (en) 2005-08-17 2009-06-09 H. Lundbeck A/S 2,3-dihydroindole compounds
US7946206B2 (en) * 2007-11-21 2011-05-24 Rocksmart, Llc Quick-release system
US10913736B2 (en) * 2014-08-22 2021-02-09 University Of Washington Specific inhibitors of methionyl-tRNA synthetase
WO2017207340A1 (de) 2016-05-31 2017-12-07 Bayer Pharma Aktiengesellschaft Neue substituierte benzimidazole, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
DK93087A (da) * 1986-02-27 1987-08-28 Duphar Int Res Hidtil ukendte aryl substituerede (n-piperidinyl)methyl- og (n-piperazinyl)methylazoler med antipsykotiske egenskaber
CA2022451C (en) * 1989-08-03 2001-01-23 Albert Anthony Carr Anti-psychotic piperidynl benzimidazole compounds
JPH03102485U (de) * 1990-02-08 1991-10-24
HUT71799A (en) * 1993-03-01 1996-02-28 Merck Sharp & Dohme Pyrrolo-pyridine derivatives, pharmaceutical compositions containing the same, process for producing them

Also Published As

Publication number Publication date
JPH08508289A (ja) 1996-09-03
EP0691960B1 (de) 1997-12-03
CA2159220A1 (en) 1994-10-13
WO1994022839A1 (en) 1994-10-13
DE69407176D1 (de) 1998-01-15
AU6286994A (en) 1994-10-24
DE69407176T2 (de) 1998-07-02
US5792768A (en) 1998-08-11
ATE160774T1 (de) 1997-12-15
AU679049B2 (en) 1997-06-19
GB9306578D0 (en) 1993-05-26
EP0691960A1 (de) 1996-01-17

Similar Documents

Publication Publication Date Title
ES2171768T3 (es) Inhibidores de la resorcion osea y antagonistas de receptores de vitronectina.
ATE160774T1 (de) Antipsychotische benzimidazolderivate
ES2164054T3 (es) Antagonistas de receptores de endotelina.
AR033377A1 (es) Derivados de benzocicloalquilenilamina como antagonistas de receptores muscarinicos
PT1135153E (pt) Utilizacoes para antagonistas e agonistas de receptores eph para tratar desordens vasculares
NI200900100A (es) Antagonistas de receptor de orexina de diazepan sustituido
CR20110228A (es) Antagonistas del receptor de orexina de isonicotinamida
ES2196072T3 (es) Empleo de compuestos heterociclicos como ligandos de dopamina-d3.
BR9206237A (pt) Uso de derivados de tetrahidrocarbazole como receptores agonistas 5-HT1.
ECSP067116A (es) Antagonistas del receptor 2 de citocina quimioatrayente de sales cuaternarias
BR0007595A (pt) 4-(heterociclisulfonamido)-5-metóxi-6-(2-metoxifenó xi)-2-fenil-ou piridilpirimidinas como antagonistas de receptor de endotelina
CL2007000396A1 (es) Compuestos derivados de benzoil-piperidina, moduladores del receptor 5ht2/d3; composicion farmaceutica que los comprende;y su uso en el tratamiento y/o prevencion de patologias delsnc, tales como psicosis, esquizofrenia, depresion, ansiedad,adiccion a drogas y problemas cognitivos.
MX9300842A (es) Antagonistas de endotelina de sulfonamida.
ES2138977T3 (es) Agonistas muscarinicos.
SV2008002929A (es) Uso de un antagonista de cb1 para tratar efectos secundarios y sintomas negativos de la esquizofrenia
BG99885A (en) Pyrene-pyridine derivatives
ES2058342T3 (es) Pirroles, pirazoles y triazoles sustituidos antagonistas de la angiotensina ii.
CR9088A (es) Antagonistas del receptor 2 de citocina quimioatrayente de dipiperidina sustituida
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
ES2156934T3 (es) Compuestos que presentan una potente actividad de antagonistas del calcio y de antioxidantes y su utilizacion como agentes citoprotectores.
CL2008002911A1 (es) Compuestos derivados de [arilo heteroarilo]-[1-piperidinilo susutituido]metanona, antagonista del receptor ccr-2, ccr-3, ccr-5; proceso de preparacion; composicion farmaceutica que los comprende; y su uso en el tratamiento de la enfermedad arterial periferica oclusiva e isquemia critica de las extremidades, entre otras.
DOP2003000624A (es) Derivados de tropano como moduladores de ccr5
ECSP066475A (es) Derivados de tropano
ATE160779T1 (de) Antipsychotische indazolderivate
MX2020012030A (es) Lactamas funcionalizadas novedosas como moduladores del receptor 7 de 5-hidroxitriptamina y su método de uso.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 691960

Country of ref document: ES